Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 242

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 242
---
 of Financial Position as of June 30, 2024” section for details. (6)To reflect the elimination of interest costs of borrowings provided by the Parent to OmnigenicsAI and Heritas Argentina, due to the capitalization of said liabilities described in footnote (7) under “ Adjustments to Unaudited Pro Forma Combined Consolidated Statement of Financial Position as of June 30, 2024.”The eliminated interest expense corresponds to the accrual in OmnigenicsAI’s combined financial statements corresponding to said capitalized loans. Adjustments to Unaudited Pro Forma Combined Consolidated Statement of Financial Position as of June 30, 2024 The pro forma notes and adjustments, based on preliminary estimates that could change materially as additional information is obtained, are as follows: (1)On December 4, 2024, the Company held an extraordinary general meeting of shareholders, during which 5,077,568 Public Shares were tendered for redemption at a price of approximately $11.98 per share. This resulted in a total redemption payment of $60,856,059, leaving a net trust account balance of approximately $6,233,015 and 520,056 Public Shares outstanding post -redemption. This event significantly reduces the Trust Account balance and the number of Public Shares outstanding, which affects the pro forma calculations and dilution metrics. Accordingly, although these redemptions occurred after the reporting period at the price per share described above, their effects have been reflected in the pro forma Statement of Financial Position using the fair value as of June 30, 2024, which was $11.60 per share (fair value applied in the valuation of the liability for “Common stock subject to possible redemption” in APx financial statements as of said date). The subsequent redemptions impacted the pro forma Statement of Financial Position as follows: (a)Decrease in the Investment held in Trust Account of $58,670,685. (b)Decrease in the Accrued interests receivable of $248,998. (c)Decrease in the liability for Common stock subject to possible redemption of $58,919,683 (5,077,568shares considered at fair value of $11.60).

107

(2)To reflect the release of cash from marketable securities held in the Trust Account together with the Accrued interest receivable in each redemption scenario. For scenario1, which assumes no redemption of Public Shares, no release of cash is reflected. For scenario